{
  "schema_version": "0.1.0",
  "case_id": "HR-ML048",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML048",
    "display_name": "Paul Robeson",
    "aliases": [
      "Paul Leroy Robeson",
      "Paul LeRoy Robeson"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1898-04-09",
          "display": "April 9, 1898",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1898",
              "display": "1898",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1976-01-23",
          "display": "January 23, 1976",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1976",
              "display": "1976",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0012"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML048-SYN",
      "ssn": "000-48-2647",
      "date_of_birth": "1967-04-09",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Theodore Bankole-Ashworth, MD",
      "fictional_consultant": {
        "name": "Esther Lindqvist-Adebayo, MD",
        "specialty": "Psychiatry (mood disorders)"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1898-04-09",
        "display": "April 9, 1898",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Princeton, New Jersey.",
      "claim_ids": [
        "CLM-0001",
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1919",
        "display": "1919",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Graduates from Rutgers as valedictorian.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1923",
        "display": "1923",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Law degree from Columbia Law School.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1950",
        "display": "1950",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Passport cancelled by the State Department; blacklisting and loss of income follow.",
      "claim_ids": [
        "CLM-0005",
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1955",
        "display": "1955",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Prostate surgery and a first breakdown followed by deep depression.",
      "claim_ids": [
        "CLM-0008",
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1956",
        "display": "1956",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Called before the House Un-American Activities Committee.",
      "claim_ids": [
        "CLM-0007"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1958",
        "display": "1958",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Passport restored after eight years.",
      "claim_ids": [
        "CLM-0018"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "1961-03",
        "display": "March 1961",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Suicide attempt in Moscow; illness ends his career.",
      "claim_ids": [
        "CLM-0010",
        "CLM-0013",
        "CLM-0015"
      ]
    },
    {
      "event_id": "EVT-0009",
      "date": {
        "iso": "1961-09",
        "display": "September 1961",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Admitted to the Priory clinic in London; many electroconvulsive treatments.",
      "claim_ids": [
        "CLM-0011",
        "CLM-0014"
      ]
    },
    {
      "event_id": "EVT-0010",
      "date": {
        "iso": "1963-12",
        "display": "December 1963",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Returns to the United States after hospital care in East Berlin.",
      "claim_ids": [
        "CLM-0012"
      ]
    },
    {
      "event_id": "EVT-0011",
      "date": {
        "iso": "1966",
        "display": "1966",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Moves to Philadelphia to live with his sister.",
      "claim_ids": [
        "CLM-0016"
      ]
    },
    {
      "event_id": "EVT-0012",
      "date": {
        "iso": "1976-01-23",
        "display": "January 23, 1976",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies in Philadelphia of complications of a stroke.",
      "claim_ids": [
        "CLM-0017"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "Paul Leroy Robeson was born on April 9, 1898, in Princeton, New Jersey.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0012",
          "relationship": "context",
          "locator": "roster birth year 1898"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "His father, the Rev. William Drew Robeson, was a minister, and his mother was Maria Louisa Bustill.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; his parents are given no role in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "In 1915 he was awarded a four-year academic scholarship to Rutgers, where he was elected to Phi Beta Kappa and graduated as valedictorian in 1919; he had been named to college All-America football teams.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In 1923 he earned a law degree from Columbia Law School.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Recorded as a documented education fact only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "In 1950 the State Department cancelled his passport, saying his overseas travel was 'contrary to the best interests of the United States'.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the sustained political persecution in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0018",
      "statement": "His passport was restored in 1958, after eight years, following a Supreme Court ruling in a similar case that the withdrawal of a passport violated a citizen's constitutionally protected liberty.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the true-frame visits.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "He was blacklisted: his concerts were cancelled, record companies stopped recording him, his name was struck from the All-America teams and newsreel footage of him was destroyed, and his yearly income fell from more than $150,000 to less than $3,000.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the loss of work and income in the modern social history.",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "In 1956 he was called before the House Un-American Activities Committee, where he invoked the Fifth Amendment and closed by saying, 'You gentlemen belong with the Alien and Sedition Acts, and you are the nonpatriots, and you are the un-Americans, and you ought to be ashamed of yourselves.'",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0005",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "His biographer Martin Duberman describes his first breakdown in 1955, after health problems related to prostate surgery: a period of intense, driven energy that was followed by a deep depression.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The documented anchor for the recurrent depression; reported through a secondary account of the Duberman biography.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "A writer reviewing the Duberman biography has argued that he had the classic symptoms of bipolar disorder; no formal diagnosis of bipolar disorder in his lifetime is quoted.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "Retrospective interpretation; not adopted. The modern episode screens for bipolar disorder (MDQ and a structured interview) and records why it is not diagnosed.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "In March 1961, in Moscow, he became acutely paranoid and suicidal and made a suicide attempt.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "After the index date; no modern visit falls in this period.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0011",
      "statement": "From September 1961 he was treated at the Priory clinic in London for nearly two years, where he received a large number of electroconvulsive treatments, 54 by his son's later count, in five courses over about twenty months, together with heavy doses of drugs; reviewers of the Duberman biography note electroshock for recurrent depression and suicide attempts.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "After the index date. Contrast for teaching: modern ECT is offered only after informed consent, given under general anesthesia with a muscle relaxant, usually right unilateral with an ultrabrief pulse, in a defined course with cognitive testing before and during treatment; this record does not judge whether his treatment met the standards of its time.",
      "source_links": [
        {
          "source_id": "SRC-0009",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0012",
      "statement": "He later spent time in a psychiatric hospital in East Berlin and returned to the United States in December 1963.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "After the index date.",
      "source_links": [
        {
          "source_id": "SRC-0007",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0009",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0013",
      "statement": "Illness ended his professional career in 1961.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0014",
      "statement": "His son, Paul Robeson Jr., believed that his father had been poisoned by United States intelligence with a mind-altering drug and that a doctor who treated him had links to the MK-Ultra program.",
      "evidence_grade": "R",
      "certainty": "disputed",
      "clinical_interpretation": "An allegation by a relative, reported as his belief; not confirmed by the cited sources and not adopted. The modern episode makes no claim about it.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0015",
      "statement": "Federal agencies kept files on him: the CIA opened a file in 1943, and the FBI kept a 'status of health' file on him between April and June 1961; his biographer drew on his FBI files.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Supports treating his concern about surveillance in the modern episode as realistic rather than delusional.",
      "source_links": [
        {
          "source_id": "SRC-0010",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0008",
          "relationship": "context"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0016",
      "statement": "From 1966 he lived in Philadelphia under the care of his sister Marian until his death, and lived as a recluse.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "After the index date; his sister is history only.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0017",
      "statement": "He died of complications of a stroke on January 23, 1976, in Philadelphia, at the age of 77.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Paul Robeson",
      "publisher": "Paul Robeson Cultural Center, Rutgers University-New Brunswick",
      "url": "https://prcc.rutgers.edu/paul-robeson",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "University biography; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Paul LeRoy Robeson",
      "publisher": "Paul Robeson House and Museum, Philadelphia",
      "url": "https://paulrobesonhouse.org/paul-robeson/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Museum biography; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "A Conscious Choice: Paul Robeson's Legacy",
      "publisher": "Rutgers University",
      "url": "https://www.rutgers.edu/news/conscious-choice-paul-robesons-legacy",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "University news feature; facts and one quotation used with citation."
    },
    {
      "source_id": "SRC-0004",
      "title": "ROBESON, PAUL LEROY (1898 - 1976), actor, singer and political activist (Jamie Griffiths)",
      "publisher": "Dictionary of Welsh Biography, National Library of Wales",
      "url": "https://biography.wales/article/s14-ROBE-LER-1898",
      "source_type": "scholarly",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "National biography entry; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "What Paul Robeson Said (Gilbert King)",
      "publisher": "Smithsonian Magazine",
      "url": "https://www.smithsonianmag.com/history/what-paul-robeson-said-77742433/",
      "source_type": "biography",
      "published": "2011-09-13",
      "accessed": "2026-11-05",
      "rights_note": "Magazine history article citing Duberman and the HUAC transcript; facts and a quotation used with citation."
    },
    {
      "source_id": "SRC-0006",
      "title": "Paul Robeson's Appearance Before the House Un-American Activities Committee (1956)",
      "publisher": "The American Yawp Reader (Stanford University Press)",
      "url": "https://www.americanyawp.com/reader/25-the-cold-war/paul-robesons-appearance-before-the-house-un-american-activities-committee-1956/",
      "source_type": "primary",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Edited excerpt of the committee transcript (Investigation of the Unauthorized Use of U.S. Passports, 1956); facts used with citation."
    },
    {
      "source_id": "SRC-0007",
      "title": "The Great Paul Robeson's Mental Illness (Ingrid Blaufarb Hughes)",
      "publisher": "Psychology Today",
      "url": "https://www.psychologytoday.com/gb/blog/not-the-whole-person/201912/the-great-paul-robesons-mental-illness",
      "source_type": "other",
      "published": "2019-12-30",
      "accessed": "2026-11-05",
      "rights_note": "Blog essay that summarizes Duberman's Paul Robeson (Knopf); facts attributed to Duberman used with citation; the author's own interpretation recorded as R."
    },
    {
      "source_id": "SRC-0008",
      "title": "Paul Robeson: A Biography, by Martin Bauml Duberman (review)",
      "publisher": "Kirkus Reviews",
      "url": "https://www.kirkusreviews.com/book-reviews/a/martin-bauml-duberman/paul-robeson-a-biography/",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Book review; used only for what it says the biography covers."
    },
    {
      "source_id": "SRC-0009",
      "title": "Paul Robeson's ECT at the Priory",
      "publisher": "ECT Statistics (blog)",
      "url": "https://ectstatistics.wordpress.com/2013/01/13/paul-robesons-ect-at-the-priory/",
      "source_type": "other",
      "published": "2013-01-13",
      "accessed": "2026-11-05",
      "rights_note": "Blog post quoting Paul Robeson Jr., The Undiscovered Paul Robeson: Quest for Freedom, 1939-1976 (Wiley, 2010), pp. 326 and 340; used only for the quoted figures, which are attributed to that book."
    },
    {
      "source_id": "SRC-0010",
      "title": "Did the CIA Drug Paul Robeson?",
      "publisher": "Democracy Now!",
      "url": "https://www.democracynow.org/1999/7/1/did_the_cia_drug_paul_robeson",
      "source_type": "other",
      "published": "1999-07-01",
      "accessed": "2026-11-05",
      "rights_note": "Broadcast summary reporting his son's belief and the agencies' files; used for what it reports."
    },
    {
      "source_id": "SRC-0012",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-05",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-03-09",
    "index_age": 58,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize and treat recurrent severe major depression in a 58-year-old Black singer, actor and activist under sustained political persecution, as the APA 2019 and VA/DoD 2022 guidelines and the CMID depression monograph advise: PHQ-9 and GAD-7, a structured diagnostic interview, bipolar screening with the MDQ before an antidepressant, a structured suicide-risk assessment with a safety plan, means counseling and the 988 Suicide & Crisis Lifeline, and tests to exclude medical causes; treating realistic fears of surveillance as realistic rather than as paranoia, and attending to the documented racial disparities in the diagnosis of depression, its treatment and access to ECT; behavioral activation with measurement-based care; adequate trials of an SSRI (sertraline to 200 mg) and an SNRI (venlafaxine to 225 mg), then aripiprazole augmentation for treatment-resistant depression with metabolic monitoring; and an informed consent discussion about modern ECT (general anesthesia, right unilateral ultrabrief pulse, a defined course with cognitive testing) and its alternatives (rTMS and esketamine), decided against for now and kept available. The modern record contrasts careful, consented, measured modern ECT with what is documented about the many treatments he received years later, without asserting the disputed allegations about his care. It is a teaching case, not a claim about his real illness or care.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-03-09",
        "purpose": "New patient visit for three months of low mood, exhaustion, poor sleep and withdrawal: depression screening, safety assessment and safety plan, tests for medical causes, and urgent psychiatric consultation"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-12",
        "purpose": "Psychiatric consultation and review: diagnosis of recurrent major depression, bipolar screening, start of sertraline and behavioral activation"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-04-20",
        "purpose": "Six-week review: minimal response; sertraline increased"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-06-08",
        "purpose": "Three-month review: no response to an adequate sertraline trial; switch to venlafaxine"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-07-27",
        "purpose": "Same-day sick visit for acute bronchitis on venlafaxine"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-08-24",
        "purpose": "Twenty-four-week review: partial response to venlafaxine; treatment-resistant depression; aripiprazole augmentation and an informed consent discussion about ECT"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-05",
        "purpose": "Periodic adult preventive visit"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "About three months of low mood, exhaustion, poor sleep with waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends, in a man of 58 under sustained political pressure; PHQ-9 22 with thoughts of being better off dead; depression suspected; medical causes being excluded and urgent psychiatric consultation arranged",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R53.83",
            "display": "Other fatigue",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic presenting problem at intake, superseded by the diagnosis at the psychiatric consultation; anchored to his documented depression and loss of work (D).",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-03-12"
      },
      {
        "id": "PRB-002",
        "display": "Major depressive disorder, recurrent, severe, without psychotic features (second episode; structured diagnostic interview; MDQ negative and no past hypomanic or manic episode on interview)",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F33.2",
            "display": "Major depressive disorder, recurrent severe without psychotic features",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern diagnosis anchored to his documented depression after the 1955 breakdown (D); the bipolar interpretation (R) is addressed and not adopted.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-03-12"
      },
      {
        "id": "PRB-003",
        "display": "Sustained political persecution: passport withheld, concerts and recordings cancelled, income lost, and surveillance by federal agencies; a major and realistic stressor, not a delusion",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z60.5",
            "display": "Target of (perceived) adverse discrimination and persecution",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic coding of his documented persecution as a social determinant of his depression.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-004",
        "display": "Acute bronchitis after a cold, without signs of pneumonia; treated without antibiotics and without dextromethorphan or decongestants because of venlafaxine; resolved",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "J20.9",
            "display": "Acute bronchitis, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic intercurrent illness; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-27",
        "abatement_date": "2026-08-24"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Sertraline 50 mg tablet, one tablet each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312941",
            "display": "sertraline 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "50 mg each morning for two weeks"
        },
        "start_date": "2026-03-12",
        "end_date": "2026-03-25",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first antidepressant started at the psychiatric consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Sertraline 100 mg tablet, one tablet each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312938",
            "display": "sertraline 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "100 mg each morning"
        },
        "start_date": "2026-03-26",
        "end_date": "2026-04-19",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase after two weeks, planned at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Sertraline 50 mg tablets, three tablets (150 mg) each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312941",
            "display": "sertraline 50 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "150 mg each morning for two weeks"
        },
        "start_date": "2026-04-20",
        "end_date": "2026-05-03",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase for a minimal response at six weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Sertraline 100 mg tablets, two tablets (200 mg) each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312938",
            "display": "sertraline 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 2,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "200 mg each morning"
        },
        "start_date": "2026-05-04",
        "end_date": "2026-06-07",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic increase to the maximum dose, planned at the six-week visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Sertraline 100 mg tablet, one tablet each morning for one week, then stop",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "312938",
            "display": "sertraline 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "100 mg each morning for one week during the switch"
        },
        "start_date": "2026-06-08",
        "end_date": "2026-06-14",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic taper during the cross-taper to venlafaxine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Venlafaxine extended-release 75 mg capsule, one capsule each morning with food",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313585",
            "display": "24 HR venlafaxine 75 MG Extended Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "75 mg each morning for one week"
        },
        "start_date": "2026-06-08",
        "end_date": "2026-06-14",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic second antidepressant (an SNRI) after a sertraline trial without response; 30-day supplies because venlafaxine is more dangerous than an SSRI in overdose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Venlafaxine extended-release 150 mg capsule, one capsule each morning with food",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313581",
            "display": "24 HR venlafaxine 150 MG Extended Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "150 mg each morning for three weeks"
        },
        "start_date": "2026-06-15",
        "end_date": "2026-07-05",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic titration planned at the switch.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "313585",
            "display": "24 HR venlafaxine 75 MG Extended Release Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 3,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "225 mg each morning; 30-day supply at a time"
        },
        "start_date": "2026-07-06",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic titration to 225 mg planned at the switch; blood pressure checked at each visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-009",
        "display": "Aripiprazole 2 mg tablet, one tablet each morning",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "602964",
            "display": "aripiprazole 2 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "2 mg each morning for two weeks"
        },
        "start_date": "2026-08-24",
        "end_date": "2026-09-06",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic augmentation for treatment-resistant depression after two adequate antidepressant trials.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MED-010",
        "display": "Aripiprazole 5 mg tablet, one tablet each morning",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "402131",
            "display": "aripiprazole 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "5 mg each morning"
        },
        "start_date": "2026-09-07",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic augmentation dose, planned when aripiprazole was started.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 14.2,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 17.1
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White cell count",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 6.1,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 240,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "panel": {
          "code": "58410-2",
          "display": "CBC panel - Blood by Automated count"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 4.2,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.05,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.7,
          "high": 1.3
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 82,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 92,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CA-V1",
        "display": "Calcium [Mass/volume] in Serum or Plasma",
        "label": "Calcium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 9.4,
        "unit": "mg/dL",
        "reference_range": {
          "low": 8.6,
          "high": 10.3
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "17861-6",
            "display": "Calcium [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 1.8,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.4,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 420,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-FOL-V1",
        "display": "Folate [Mass/volume] in Serum or Plasma",
        "label": "Folate",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 9.5,
        "unit": "ng/mL",
        "reference_range": {
          "low": 3.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2284-8",
            "display": "Folate [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TESTO-V1",
        "display": "Testosterone [Mass/volume] in Serum or Plasma",
        "label": "Testosterone, total (morning)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 420,
        "unit": "ng/dL",
        "reference_range": {
          "low": 264,
          "high": 916
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2986-8",
            "display": "Testosterone [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-09",
        "value": 5.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result in the workup for medical causes of depression; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 22,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PHQ-9: severe; item 9 scored 1 (thoughts of being better off dead on several days). Anchored to his documented depression; not a claim about his real symptoms on any date.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GAD7-V1",
        "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
        "label": "GAD-7",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 12,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "70274-6",
            "display": "Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic GAD-7: moderate anxiety, mostly worry and restlessness.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-V1",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic alcohol screen; an occasional glass of wine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-MOCA-V1",
        "display": "Total score [MoCA]",
        "label": "MoCA",
        "status": "final",
        "effective_date": "2026-03-09",
        "value": 28,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72172-0",
            "display": "Total score [MoCA]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline cognitive screen; normal. Kept as the baseline should ECT ever be considered.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V3",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-04-20",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sodium six weeks into sertraline; normal (SSRIs can lower sodium in older adults).",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V3",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-04-20",
        "value": 19,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PHQ-9 at about six weeks; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-06-08",
        "value": 137,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sodium on sertraline 200 mg; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V4",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-06-08",
        "value": 17,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PHQ-9 after an adequate sertraline trial; a 23 percent fall, below a response; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V5",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 136,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V5",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 94,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V5",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 5.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6,
          "text": "Below 5.7% is normal; 5.7 to 6.4% prediabetes"
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V5",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 204,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "H",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V5",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 46,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-TRIG-V5",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 130,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V5",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol (calculated)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-24",
        "value": 132,
        "unit": "mg/dL",
        "reference_range": {
          "high": 129
        },
        "interpretation": "H",
        "panel": {
          "code": "24331-1",
          "display": "Lipid 1996 panel - Serum or Plasma"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic result: sodium on venlafaxine, and metabolic baseline before aripiprazole.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-08-24",
        "value": 13,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic PHQ-9 after an adequate venlafaxine trial: a partial response (41 percent fall) without remission; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-MOCA-V5",
        "display": "Total score [MoCA]",
        "label": "MoCA",
        "status": "final",
        "effective_date": "2026-08-24",
        "value": 28,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72172-0",
            "display": "Total score [MoCA]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic cognitive screen; unchanged.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V7",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-05",
        "value": 6,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 six weeks after aripiprazole was added: a response, not yet remission; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Advance care planning conversation, about 20 minutes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-10-05",
          "end": "2026-10-05"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning; records only his own general preferences.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine, inactivated, trivalent, preservative-free",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine, 20-valent (PCV20)",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination for an adult aged 50 or older with no earlier dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Zoster vaccine, recombinant, dose 1 of 2",
        "status": "completed",
        "date": "2026-10-05",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first dose for an adult aged 50 or older; dose 2 in two to six months.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Prostate surgery; reason not recorded in the cited source",
        "historical_date": {
          "iso": "1955",
          "display": "1955",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "A breakdown described by his biographer as a period of intense, driven energy followed by a deep depression",
        "historical_date": {
          "iso": "1955",
          "display": "1955",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "New patient visit for three months of low mood, exhaustion, poor sleep and withdrawal: depression screening, safety assessment and safety plan, tests for medical causes, and urgent psychiatric consultation",
        "status": "finished",
        "date": "2026-03-09",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Psychiatric consultation and review: diagnosis of recurrent major depression, bipolar screening, start of sertraline and behavioral activation",
        "status": "finished",
        "date": "2026-03-12",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Review of results, with psychiatric consultation the same day",
          "hpi": {
            "narrative": "Mr. Robeson returns three days after his first visit and is seen by Dr. Lindqvist-Adebayo of psychiatry today. His blood tests are normal. He still wakes at three in the morning and cannot get back to sleep, has little appetite, and has spent most of the three days at home. On two of the days he again thought he would be better off dead, without any wish or plan to act; he kept to his safety plan, has put his medicines in a locked box, and has the 988 number in his phone. He has had no alcohol. He asked again who can read his record, and the protections were explained. In the structured interview with Dr. Lindqvist-Adebayo he described a first depression about two years ago, after surgery, which lifted slowly over some months without treatment. Before it he had some weeks of intense, absorbed work, sleeping his usual hours, without elation, irritability, racing thoughts or risky behavior.",
            "elements": [
              {
                "label": "Symptoms",
                "value": "Early waking, poor appetite, low mood and withdrawal unchanged"
              },
              {
                "label": "Safety",
                "value": "Passive thoughts of death on two days; no intent or plan; medicines locked"
              },
              {
                "label": "Results",
                "value": "Blood count, metabolic panel, calcium, TSH, B12, folate, testosterone and A1c normal; HIV and syphilis tests negative"
              },
              {
                "label": "Consultation",
                "value": "Structured interview and bipolar screening with psychiatry today"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Exhausted; poor appetite; weight 98.8 kg"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood, loss of interest, early waking, passive thoughts of death on two days; no hallucinations"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No headache, weakness or memory complaint"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary symptoms since the prostate surgery"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired, well groomed; weight 98.8 kg; blood pressure 126/78, pulse 74"
            },
            {
              "system": "Psychiatric",
              "finding": "Slowed speech and movement; mood 'worn through'; constricted affect; logical thought; no delusions; passive thoughts of death without intent or plan; insight good"
            },
            {
              "system": "Neurological",
              "finding": "No focal signs; no tremor"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Major depressive disorder, recurrent, severe, without psychotic features",
              "assessment": "The structured interview confirms a second major depressive episode, severe, without psychotic features. The MDQ is negative (5 of 13 items, not clustered in one period) and the interview finds no past hypomanic or manic episode: the earlier period of intense work had no reduced need for sleep, elation, irritability or risky behavior. The tests exclude thyroid disease, anemia, low B12 or folate, low testosterone, high calcium, diabetes, HIV and syphilis as causes; he takes no medicine that causes depression. His fear of being watched is realistic for a man in his position and is not a psychotic symptom; recording it as paranoia would repeat a documented pattern of misdiagnosis in Black patients. Dr. Lindqvist-Adebayo and I agree on the plan",
              "plan": [
                "Sertraline 50 mg each morning from today, rising to 100 mg in two weeks after a nurse's phone check",
                "Behavioral activation weekly with a psychologist he has chosen",
                "Six-week review; sodium then",
                "Watch for any rise in energy with less need for sleep after the antidepressant starts, and call if it happens"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Political persecution and loss of income",
              "assessment": "A real and continuing stressor that sustains the depression",
              "plan": [
                "Social worker to help with income and costs",
                "Therapy to include coping with the persecution, not only the symptoms"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline and at least monthly during acute treatment (CMID)",
              "status": "up_to_date",
              "detail": "22 three days ago, item 9 scored 1",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Structured diagnostic interview",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Second major depressive episode, severe, without psychotic features; no past hypomania or mania",
              "guideline_ids": [
                "GL-APA-DEP-2019",
                "GL-VADOD-MDD-2022",
                "GL-DISPARITY-2014"
              ]
            },
            {
              "domain": "survey",
              "measure": "Mood Disorder Questionnaire (MDQ)",
              "cadence": "Once at the initial depression workup (CMID)",
              "status": "completed_today",
              "detail": "5 of 13 items, not in one period and without serious problems: negative",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "Passive thoughts of death on two days; no intent, plan or preparation; medicines locked; 988 in his phone",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Tests for medical causes of depression",
              "cadence": "At diagnosis",
              "status": "up_to_date",
              "detail": "Blood count, metabolic panel, calcium, TSH, B12, folate, morning testosterone and A1c normal three days ago; HIV and syphilis tests negative",
              "guideline_ids": [
                "GL-VADOD-MDD-2022",
                "GL-APA-DEP-2019"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognitive screen (MoCA)",
              "cadence": "Baseline, and before and during any course of ECT",
              "status": "up_to_date",
              "detail": "MoCA 28 three days ago",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Start of sertraline",
              "cadence": "At the start, at two weeks and with each dose change",
              "status": "completed_today",
              "detail": "50 mg from today; nausea, sleep change and sexual side effects explained; nurse phone check in two weeks before the increase",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sodium (SSRI or SNRI in an older adult)",
              "cadence": "Baseline, about four to six weeks after starting, and with symptoms",
              "status": "up_to_date",
              "detail": "140 mmol/L at baseline; next at six weeks",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Watch for hypomania or mixed features after starting or changing an antidepressant",
              "cadence": "Every visit; repeat the MDQ if features emerge",
              "status": "completed_today",
              "detail": "Explained what to watch for; none at baseline",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Behavioral activation with a psychologist",
              "cadence": "Weekly for about sixteen sessions",
              "status": "ordered",
              "detail": "First session next week with a psychologist he chose",
              "guideline_ids": [
                "GL-APA-DEP-2019",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Trust, confidentiality and culturally responsive care",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Record protections explained; his account of surveillance recorded as realistic; a therapist of his choosing",
              "guideline_ids": [
                "GL-WILLIAMS-2007",
                "GL-DISPARITY-2014"
              ]
            },
            {
              "domain": "referral",
              "measure": "Social work for income and costs",
              "cadence": "At diagnosis and as needed",
              "status": "referred",
              "detail": "First meeting with the social worker next week",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Psychiatric consultation",
              "cadence": "Within days for severe depression with thoughts of death",
              "status": "completed_today",
              "detail": "Seen today by Dr. Lindqvist-Adebayo",
              "guideline_ids": [
                "GL-VADOD-MDD-2022",
                "GL-APA-DEP-2019"
              ]
            }
          ],
          "follow_up": "Nurse phone call in two weeks before the sertraline increase. Six-week review with the PHQ-9 and sodium. Weekly behavioral activation. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-APA-DEP-2019",
            "GL-VADOD-MDD-2022",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-WILLIAMS-2007",
            "GL-DISPARITY-2014"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Six-week review: minimal response; sertraline increased",
        "status": "finished",
        "date": "2026-04-20",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Six-week review of depression treatment",
          "hpi": {
            "narrative": "Mr. Robeson returns six weeks after starting sertraline. He took 50 mg for two weeks with mild nausea that passed in a week, and after the nurse's phone check he has taken 100 mg for three and a half weeks. He has been to five behavioral activation sessions and has begun short walks and an hour of reading each day, but he still wakes early, has little pleasure, and has not sung. He has had no thoughts of being better off dead for three weeks. He has noticed no rise in energy or reduced need for sleep. He takes every dose and keeps his medicines locked.",
            "elements": [
              {
                "label": "Medicines",
                "value": "Sertraline 50 mg for two weeks, then 100 mg for three and a half weeks; every dose taken"
              },
              {
                "label": "Therapy",
                "value": "Five behavioral activation sessions"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 19 from 22; no thoughts of death for three weeks"
              },
              {
                "label": "Side effects",
                "value": "Nausea in the first week only"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; appetite a little better; weight 99.5 kg"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood and little pleasure; early waking; no thoughts of suicide; no elation"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "Nausea gone"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor or headache"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Weight 99.5 kg; blood pressure 126/78, pulse 72"
            },
            {
              "system": "Psychiatric",
              "finding": "Slowed; constricted affect, a little brighter; logical; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Recurrent major depression on sertraline",
              "assessment": "PHQ-9 22 to 19 at six weeks: a minimal response, with three and a half weeks at 100 mg. The dose can go higher before the trial is judged. Sodium 138, normal. Safety reviewed: no thoughts of suicide for three weeks; medicines locked; 988 in his phone. No signs of hypomania",
              "plan": [
                "Sertraline 150 mg each morning from today, then 200 mg in two weeks if tolerated",
                "Continue weekly behavioral activation",
                "Review in seven weeks, when he will have had about five weeks at 200 mg"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline and at least monthly during acute treatment (CMID)",
              "status": "completed_today",
              "detail": "19, down 14 percent from 22; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9 between visits, rated by the psychologist at each session",
              "cadence": "At each therapy session",
              "status": "deferred",
              "detail": "Missed: no PHQ-9 was collected about four weeks into treatment; the two-week nurse call checked side effects and safety but not the PHQ-9, and no visit was booked at four weeks. No harm judging by today's score and his safety review. Corrective action: the psychologist now rates the PHQ-9 at each weekly session and reports any rise or positive item 9 the same day",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No thoughts of suicide for three weeks; medicines locked; safety plan reviewed",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sodium (SSRI or SNRI in an older adult)",
              "cadence": "Baseline, about four to six weeks after starting, and with symptoms",
              "status": "completed_today",
              "detail": "138 mmol/L, normal",
              "observation_ids": [
                "OBS-NA-V3"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and adverse-effect review",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Every dose taken; nausea in the first week only",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adequacy of the antidepressant trial (dose and duration)",
              "cadence": "At each review: at least four to eight weeks at an adequate dose before judging response",
              "status": "completed_today",
              "detail": "Three and a half weeks at 100 mg: not yet an adequate trial; dose raised",
              "guideline_ids": [
                "GL-VADOD-MDD-2022",
                "GL-APA-DEP-2019"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Watch for hypomania or mixed features after starting or changing an antidepressant",
              "cadence": "Every visit; repeat the MDQ if features emerge",
              "status": "completed_today",
              "detail": "No elation, reduced need for sleep or racing thoughts",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Behavioral activation with a psychologist",
              "cadence": "Weekly for about sixteen sessions",
              "status": "completed_today",
              "detail": "Five sessions attended; daily walks and reading scheduled",
              "guideline_ids": [
                "GL-APA-DEP-2019",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Trust, confidentiality and culturally responsive care",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "He feels able to speak freely with his therapist",
              "guideline_ids": [
                "GL-WILLIAMS-2007"
              ]
            },
            {
              "domain": "referral",
              "measure": "Social work for income and costs",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "Meeting the social worker monthly about costs",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            }
          ],
          "follow_up": "Sertraline 200 mg in two weeks. Review in seven weeks with the PHQ-9 and sodium. Weekly behavioral activation with a PHQ-9 at each session. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-APA-DEP-2019",
            "GL-VADOD-MDD-2022",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-WILLIAMS-2007"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Three-month review: no response to an adequate sertraline trial; switch to venlafaxine",
        "status": "finished",
        "date": "2026-06-08",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Three-month review of depression treatment",
          "hpi": {
            "narrative": "Mr. Robeson returns three months after starting treatment. He has taken sertraline 200 mg each morning for five weeks, after two weeks at 150 mg, without missing doses and with only mild loose stools. He has attended every weekly behavioral activation session; the psychologist reports PHQ-9 scores in the high teens at each session, with no positive item 9. He walks most days but still has little pleasure, wakes at four, and has not sung or accepted any invitations. He has had no thoughts of suicide. He has had no elation or reduced need for sleep.",
            "elements": [
              {
                "label": "Medicines",
                "value": "Sertraline 200 mg for five weeks after two weeks at 150 mg"
              },
              {
                "label": "Therapy",
                "value": "Eleven behavioral activation sessions"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 17 from 22"
              },
              {
                "label": "Safety",
                "value": "No thoughts of suicide"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; appetite back; weight 100.2 kg"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Little pleasure, early waking, low drive; no thoughts of suicide; no elation"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Mild loose stools on 200 mg"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Weight 100.2 kg; blood pressure 128/80, pulse 74"
            },
            {
              "system": "Psychiatric",
              "finding": "Slowed; affect constricted; logical; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Recurrent major depression without response to sertraline",
              "assessment": "PHQ-9 22 to 17 after an adequate trial (five weeks at the maximum dose and twelve weeks in all): a 23 percent fall, short of a response. Sodium 137. Safety reviewed: no thoughts of suicide; medicines locked; 988 in his phone. Discussed with Dr. Lindqvist-Adebayo by phone: with no response rather than a partial one, switching to an SNRI is preferred over augmenting sertraline. ECT is not indicated now: there are no psychotic features, he is eating and drinking, and he is not acutely suicidal",
              "plan": [
                "Cross-taper: sertraline 100 mg for one week, then stop; venlafaxine extended-release 75 mg for one week, 150 mg for three weeks, then 225 mg",
                "Blood pressure at every visit on venlafaxine",
                "30-day supplies, because venlafaxine is more dangerous than an SSRI in overdose; medicines stay locked",
                "Call for agitation, sweating, tremor or fever during the switch"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline and at least monthly during acute treatment (CMID)",
              "status": "completed_today",
              "detail": "17, down 23 percent from 22; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9 between visits, rated by the psychologist at each session",
              "cadence": "At each therapy session",
              "status": "completed_today",
              "detail": "Rated at each session since the last visit; no positive item 9 reported",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No thoughts of suicide; medicines locked; safety plan reviewed",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sodium (SSRI or SNRI in an older adult)",
              "cadence": "Baseline, about four to six weeks after starting, and with symptoms",
              "status": "completed_today",
              "detail": "137 mmol/L, normal",
              "observation_ids": [
                "OBS-NA-V4"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adequacy of the antidepressant trial (dose and duration)",
              "cadence": "At each review: at least four to eight weeks at an adequate dose before judging response",
              "status": "completed_today",
              "detail": "Adequate trial: five weeks at 200 mg; no response; switch to venlafaxine",
              "guideline_ids": [
                "GL-VADOD-MDD-2022",
                "GL-APA-DEP-2019"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and adverse-effect review",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Every dose taken; mild loose stools",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Switch safety: serotonin syndrome and discontinuation symptoms",
              "cadence": "During a cross-taper",
              "status": "completed_today",
              "detail": "Warning signs explained; sertraline tapered over one week",
              "guideline_ids": [
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Blood pressure (venlafaxine)",
              "cadence": "Baseline and at every visit on venlafaxine",
              "status": "completed_today",
              "detail": "Baseline 128/80 before venlafaxine",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Overdose risk and supply",
              "cadence": "With each prescription",
              "status": "completed_today",
              "detail": "30-day supplies; locked box",
              "guideline_ids": [
                "GL-SUICIDE-2024",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Watch for hypomania or mixed features after starting or changing an antidepressant",
              "cadence": "Every visit; repeat the MDQ if features emerge",
              "status": "completed_today",
              "detail": "No signs of hypomania",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Behavioral activation with a psychologist",
              "cadence": "Weekly for about sixteen sessions",
              "status": "completed_today",
              "detail": "Eleven sessions; activity schedule continuing",
              "guideline_ids": [
                "GL-APA-DEP-2019",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ECT indications",
              "cadence": "At each review of a severe episode",
              "status": "not_indicated",
              "detail": "No psychosis, refusal of food or drink, or acute suicidal risk; revisit if a second trial fails",
              "guideline_ids": [
                "GL-APA-ECT-2001",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Social work for income and costs",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "Monthly meetings continue",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            }
          ],
          "follow_up": "Nurse phone check at one week of the switch. Review at about eleven weeks on venlafaxine with the PHQ-9, sodium and blood pressure. Weekly behavioral activation. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-APA-DEP-2019",
            "GL-VADOD-MDD-2022",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-APA-ECT-2001"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Twenty-four-week review: partial response to venlafaxine; treatment-resistant depression; aripiprazole augmentation and an informed consent discussion about ECT",
        "status": "finished",
        "date": "2026-08-24",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Twenty-four-week review of depression treatment",
          "hpi": {
            "narrative": "Mr. Robeson returns eleven weeks after the switch to venlafaxine; he has taken 225 mg each morning for seven weeks. He sleeps five and a half hours, walks every morning, and has begun to read and see one or two old friends, but he still has little pleasure in music and has not sung in public. The cough from four weeks ago has gone. He sweats a little more than before. He has had no thoughts of suicide since the spring and no elation. He has completed sixteen behavioral activation sessions and continues fortnightly with his psychologist, who reports PHQ-9 scores in the low to mid teens. He asked what else can be done, including whether he would need shock treatment.",
            "elements": [
              {
                "label": "Medicines",
                "value": "Venlafaxine 225 mg for seven weeks, eleven weeks in all"
              },
              {
                "label": "Mood",
                "value": "PHQ-9 13 from 22: partial response"
              },
              {
                "label": "Side effects",
                "value": "Mild sweating; blood pressure 134/84"
              },
              {
                "label": "Question",
                "value": "What else can be done, including ECT"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Mild sweating; weight 101.0 kg"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Low mood on most days, little pleasure in music; no thoughts of suicide; no elation"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Cough gone"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No palpitations or headache"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No memory complaint or tremor"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Weight 101.0 kg, BMI 28.0; blood pressure 134/84, pulse 78"
            },
            {
              "system": "Neurological",
              "finding": "No tremor, rigidity or abnormal movements; abnormal involuntary movement examination normal"
            },
            {
              "system": "Psychiatric",
              "finding": "Less slowed; affect a little fuller; logical; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Treatment-resistant recurrent major depression",
              "assessment": "PHQ-9 22 to 13 after a second adequate trial, of a different class: a partial response without remission, so the depression is treatment-resistant. Sodium 136; blood pressure 134/84, a small rise on venlafaxine that does not need a change. MoCA 28, unchanged. Safety reviewed: no thoughts of suicide; medicines locked; 988 in his phone. Options were discussed with him and with Dr. Lindqvist-Adebayo: augmentation with aripiprazole, lithium or a second antidepressant; ECT; rTMS; and esketamine nasal spray. For ECT, informed consent was discussed as a conversation, not a form: it is given under general anesthesia with a muscle relaxant and monitoring, usually right unilateral with an ultrabrief pulse to limit memory effects, two or three times a week for a defined course of about six to twelve treatments, with cognitive testing before and during the course; its benefits, risks (anesthesia, headache, muscle aches, and memory loss for events around the course) and alternatives were explained, and he was told he could decline or stop at any time. ECT is not needed now: he has no psychosis, is eating and drinking, and is not suicidal, and he chose augmentation first. Black patients receive ECT less often than white patients with the same diagnosis, so the offer stands on equal terms if augmentation fails. rTMS (daily sessions for about six weeks) and esketamine (twice weekly in the clinic, with blood pressure checks) remain alternatives",
              "plan": [
                "Aripiprazole 2 mg each morning, rising to 5 mg in two weeks",
                "Continue venlafaxine 225 mg",
                "Weight at four, eight and twelve weeks; A1c and lipids again at twelve weeks; movement examination in six months",
                "Call for restlessness, stiffness or tremor",
                "ECT, rTMS or esketamine if there is no clear improvement within about eight weeks, or at once if he becomes unable to eat or drink, psychotic or acutely suicidal"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Political persecution and loss of income",
              "assessment": "Continuing; he is working with the social worker monthly",
              "plan": [
                "Continue social work support"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "PHQ-9",
              "cadence": "Baseline and at least monthly during acute treatment (CMID)",
              "status": "completed_today",
              "detail": "13, down 41 percent from 22: partial response; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "PHQ-9 between visits, rated by the psychologist at each session",
              "cadence": "At each therapy session",
              "status": "completed_today",
              "detail": "Rated at each session; no positive item 9 reported",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline",
              "cadence": "Every visit during active treatment",
              "status": "completed_today",
              "detail": "No thoughts of suicide since the spring; medicines locked; safety plan reviewed",
              "guideline_ids": [
                "GL-SUICIDE-2024"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Sodium (SSRI or SNRI in an older adult)",
              "cadence": "Baseline, about four to six weeks after starting, and with symptoms",
              "status": "completed_today",
              "detail": "136 mmol/L, normal",
              "observation_ids": [
                "OBS-NA-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Blood pressure (venlafaxine)",
              "cadence": "Baseline and at every visit on venlafaxine",
              "status": "completed_today",
              "detail": "134/84, up slightly from 128/80; recheck at each visit",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adequacy of the antidepressant trial (dose and duration)",
              "cadence": "At each review: at least four to eight weeks at an adequate dose before judging response",
              "status": "completed_today",
              "detail": "Second adequate trial (seven weeks at 225 mg): partial response; treatment-resistant",
              "guideline_ids": [
                "GL-VADOD-MDD-2022",
                "GL-APA-DEP-2019"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Adherence and adverse-effect review",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Every dose taken; mild sweating",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Watch for hypomania or mixed features after starting or changing an antidepressant",
              "cadence": "Every visit; repeat the MDQ if features emerge",
              "status": "completed_today",
              "detail": "No signs of hypomania",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognitive screen (MoCA)",
              "cadence": "Baseline, and before and during any course of ECT",
              "status": "completed_today",
              "detail": "28, unchanged; kept as a baseline in case ECT is chosen later",
              "observation_ids": [
                "OBS-MOCA-V5"
              ],
              "guideline_ids": [
                "GL-APA-ECT-2001",
                "GL-APA-ECT-2024"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "ECT informed consent discussion and alternatives (rTMS, esketamine)",
              "cadence": "When depression is treatment-resistant or severe",
              "status": "completed_today",
              "detail": "Discussed; ECT not started now by his choice and because there is no urgent indication; available on equal terms if augmentation fails",
              "guideline_ids": [
                "GL-APA-ECT-2001",
                "GL-APA-ECT-2024",
                "GL-VADOD-MDD-2022",
                "GL-SPRENGER-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Weight and BMI on aripiprazole",
              "cadence": "Baseline, 4, 8 and 12 weeks, then quarterly (CMID)",
              "status": "completed_today",
              "detail": "Baseline 101.0 kg, BMI 28.0 before aripiprazole",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c or fasting glucose, and lipids, on aripiprazole",
              "cadence": "Baseline, 12 weeks, then yearly (CMID)",
              "status": "completed_today",
              "detail": "A1c 5.6%, glucose 94 mg/dL; total cholesterol 204, HDL 46, triglycerides 130, LDL 132 mg/dL",
              "observation_ids": [
                "OBS-GLU-V5",
                "OBS-A1C-V5",
                "OBS-CHOL-V5",
                "OBS-HDL-V5",
                "OBS-TRIG-V5",
                "OBS-LDL-V5"
              ],
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Abnormal Involuntary Movement Scale",
              "cadence": "Baseline, then every six months on an antipsychotic (CMID)",
              "status": "completed_today",
              "detail": "Baseline examination normal",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Behavioral activation with a psychologist",
              "cadence": "Weekly for sixteen sessions, then fortnightly",
              "status": "completed_today",
              "detail": "Sixteen sessions completed; fortnightly sessions continue",
              "guideline_ids": [
                "GL-APA-DEP-2019",
                "GL-VADOD-MDD-2022"
              ]
            },
            {
              "domain": "referral",
              "measure": "Social work for income and costs",
              "cadence": "Monthly",
              "status": "completed_today",
              "detail": "Monthly meetings continue",
              "guideline_ids": [
                "GL-CMID-2026",
                "GL-VADOD-MDD-2022"
              ]
            }
          ],
          "follow_up": "Nurse phone check in two weeks before the aripiprazole increase. Preventive visit in six weeks with the PHQ-9 and weight. Twelve-week metabolic tests. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-APA-DEP-2019",
            "GL-VADOD-MDD-2022",
            "GL-SUICIDE-2024",
            "GL-CMID-2026",
            "GL-APA-ECT-2001",
            "GL-APA-ECT-2024",
            "GL-SPRENGER-2025",
            "GL-WILLIAMS-2007"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Same-day sick visit for acute bronchitis on venlafaxine",
        "status": "finished",
        "date": "2026-07-27",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Cough for five days after a cold",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Mr. Robeson called this morning and was seen the same day. A week ago he had a sore throat and a runny nose, and for five days he has had a cough, worse at night, with a little clear sputum. He has had no fever, breathlessness, chest pain or blood in the sputum. The cough is keeping him awake and he wants to protect his voice. He bought a nighttime cold medicine but did not take it after reading that it contained dextromethorphan and remembering the warning about venlafaxine. He takes venlafaxine 225 mg each morning, three weeks at the full dose, with mild sweating and no other side effects. His mood is a little better than in the spring; he goes to his therapy sessions each week and walks most mornings. He has had no thoughts of suicide or of being better off dead.",
            "elements": [
              {
                "label": "Onset",
                "value": "Cough for five days after a cold a week ago"
              },
              {
                "label": "Character",
                "value": "Cough with a little clear sputum, worse at night"
              },
              {
                "label": "Severity",
                "value": "Disturbing his sleep; no breathlessness"
              },
              {
                "label": "Context",
                "value": "Venlafaxine 225 mg daily; has avoided a dextromethorphan cold remedy"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "No fever, chest pain or blood in the sputum"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever or chills; tired from broken sleep"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Sore throat and runny nose last week, now settling; voice a little hoarse"
            },
            {
              "system": "Respiratory",
              "status": "positive",
              "finding": "Cough with clear sputum; no wheeze, breathlessness or hemoptysis"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Mood low but improving; no thoughts of suicide"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Comfortable; temperature 37.4 °C, pulse 84, respiratory rate 16, oxygen saturation 97 percent, blood pressure 132/82"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "finding": "Mild pharyngeal redness; no exudate; ears normal"
            },
            {
              "system": "Respiratory",
              "finding": "Scattered rhonchi that clear with coughing; no crackles, wheeze or bronchial breathing"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm"
            },
            {
              "system": "Psychiatric",
              "finding": "Calm, brighter than in the spring; no thoughts of suicide"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-004",
              "display": "Acute bronchitis",
              "assessment": "Acute bronchitis after a viral cold. Pulse under 100, respiratory rate under 24, temperature under 38 °C and a normal chest examination make pneumonia unlikely, so no chest X-ray or antibiotic is needed; the cough may last two to three weeks. He was right to avoid the dextromethorphan remedy: with venlafaxine it can cause serotonin syndrome. Decongestants are also avoided because venlafaxine can raise blood pressure",
              "plan": [
                "Honey in warm drinks, steam and fluids; rest the voice",
                "Plain guaifenesin if the sputum is thick; read labels for dextromethorphan, pseudoephedrine and phenylephrine",
                "Return for fever, breathlessness, chest pain, blood in the sputum, or a cough lasting more than three weeks"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Recurrent major depression on venlafaxine",
              "assessment": "Three weeks at 225 mg. Safety reviewed: no thoughts of suicide or of being better off dead; medicines kept in the locked box; the 988 Suicide & Crisis Lifeline is in his phone. Blood pressure 132/82",
              "plan": [
                "Continue venlafaxine 225 mg and weekly behavioral activation",
                "Review in four weeks as booked"
              ]
            }
          ],
          "follow_up": "Twenty-four-week review in four weeks as booked. Return sooner for fever or breathlessness. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-ARTI-2016",
            "GL-VADOD-MDD-2022",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the bronchitis is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-10-05",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day",
          "health_risk_assessment_method": "Completed by the patient on paper in the waiting room and reviewed with him by Dr. Bankole-Ashworth",
          "hpi": {
            "narrative": "Mr. Robeson is a 59-year-old singer and actor with recurrent major depression who comes for the preventive visit booked in the spring. Six weeks ago aripiprazole was added to venlafaxine 225 mg; he has taken 5 mg each morning for four weeks. He sleeps about six and a half hours, his energy and interest have come back, and he practices every morning and sang at two community gatherings last month. He has noticed no restlessness, stiffness or tremor; his weight is up 1.4 kg in six weeks. The cough from the summer cleared within three weeks. He continues weekly behavioral activation and is planning a small recital. He has had no thoughts of suicide.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 59"
              },
              {
                "label": "Depression",
                "value": "PHQ-9 6 on venlafaxine and aripiprazole"
              },
              {
                "label": "Side effects",
                "value": "No restlessness or movement problems; weight up 1.4 kg"
              },
              {
                "label": "Safety",
                "value": "No thoughts of suicide; safety plan in place"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good and improving"
            },
            {
              "domain": "Psychosocial",
              "finding": "Persecution and loss of income remain his main stresses; he feels stronger in facing them; supported by friends and his therapist"
            },
            {
              "domain": "Substance use",
              "finding": "AUDIT-C 1 at intake, unchanged; no drug use"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks 40 minutes most mornings; swimming twice a week again"
            },
            {
              "domain": "Nutrition",
              "finding": "Regular meals; more vegetables and less fried food since the lipid results"
            },
            {
              "domain": "Sleep",
              "finding": "About six and a half hours; no snoring reported; STOP-BANG 2"
            },
            {
              "domain": "Safety",
              "finding": "No firearm at home; seat belt always; medicines kept in a locked box"
            },
            {
              "domain": "Sexual health",
              "finding": "One partner; no concerns"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever; weight up 1.4 kg in six weeks"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No change in vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "Voice clear; no hearing loss"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain or palpitations"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "Cough gone"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No change in bowel habit or bleeding"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine; no nighttime frequency"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No joint pain"
            },
            {
              "system": "Neurological",
              "status": "negative",
              "finding": "No tremor, stiffness or restlessness"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No rash"
            },
            {
              "system": "Psychiatric",
              "status": "positive",
              "finding": "Mild low mood on some days; no thoughts of suicide; PHQ-9 6"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well; weight 102.4 kg, BMI 28.4; blood pressure 130/80"
            },
            {
              "system": "Neck",
              "finding": "No lymph nodes; thyroid normal"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur"
            },
            {
              "system": "Respiratory",
              "finding": "Clear"
            },
            {
              "system": "Abdomen",
              "finding": "Soft; no mass"
            },
            {
              "system": "Neurological",
              "finding": "No tremor, rigidity or abnormal movements; abnormal involuntary movement examination normal; no akathisia"
            },
            {
              "system": "Psychiatric",
              "finding": "Warm and engaged; affect fuller; speech at a normal pace"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. Influenza, PCV20 and the first recombinant zoster dose given",
              "plan": [
                "FIT kit to return within two weeks",
                "Prostate surgery records requested before any PSA decision",
                "Hepatitis B and C screening drawn today",
                "Second zoster dose in two to six months",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Recurrent major depression, responding to augmentation",
              "assessment": "PHQ-9 6 from 22: a response, not yet remission. No akathisia or abnormal movements; weight up 1.4 kg (1.4 percent) at six weeks, below the 5 percent that would call for action. Safety reviewed: no thoughts of suicide; medicines locked; the 988 Suicide & Crisis Lifeline in his phone. ECT remains available if he relapses, as discussed in the summer",
              "plan": [
                "Continue venlafaxine 225 mg and aripiprazole 5 mg",
                "Weight at eight and twelve weeks of aripiprazole; A1c and lipids at twelve weeks",
                "Continue behavioral activation; continue treatment for at least a year after remission because the depression is recurrent"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Political persecution and loss of income",
              "assessment": "Still a major stressor; he is meeting the social worker monthly about costs",
              "plan": [
                "Continue social work support"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure screening",
              "status": "completed_today",
              "detail": "130/80 mmHg; watched on venlafaxine",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Depression screening and follow-up",
              "status": "completed_today",
              "detail": "PHQ-9 6 under treatment; item 9 scored 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Unhealthy alcohol use screening",
              "status": "up_to_date",
              "detail": "AUDIT-C 1 at intake; no change",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco use",
              "status": "completed_today",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "No earlier screening; he chose a yearly FIT over colonoscopy; kit given today",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "due",
              "detail": "Shared decision due: he had prostate surgery about two years ago whose reason is not in this chart; records requested before discussing PSA testing",
              "guideline_ids": [
                "GL-USPSTF-PROS-2018"
              ]
            },
            {
              "service": "Lipid screening and statin assessment",
              "status": "completed_today",
              "detail": "Total cholesterol 204, HDL 46, LDL 132 mg/dL six weeks ago; pooled cohort ten-year risk about 9 percent; statin offered after discussion; he chose diet and activity first, to revisit in a year",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022"
              ]
            },
            {
              "service": "Diabetes screening",
              "status": "up_to_date",
              "detail": "A1c 5.6% six weeks ago; repeat at twelve weeks of aripiprazole",
              "guideline_ids": [
                "GL-USPSTF-DM-2021",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "HIV screening",
              "status": "up_to_date",
              "detail": "Negative at intake",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "ordered",
              "detail": "Once for adults; drawn today",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "ordered",
              "detail": "Once for all adults; drawn today; vaccination to follow if not immune",
              "guideline_ids": [
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "Seasonal dose",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20, recommended from age 50",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Zoster vaccine",
              "status": "completed_today",
              "detail": "Recombinant vaccine dose 1 of 2",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "up_to_date",
              "detail": "Tdap six years ago on his card",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "Discussed; he will decide at the next visit",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Hepatitis B vaccine",
              "status": "due",
              "detail": "After the screening result, if not immune",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He wants full treatment of any illness. He named a health care agent, recorded in the confidential part of the chart and not named here. He asked that any future decision about ECT be his own, made with his own informed consent while he has capacity; this was recorded as his stated preference. To be revisited yearly.",
          "follow_up": "Mood review with weight in two weeks, at eight weeks of aripiprazole; twelve-week metabolic tests. FIT result and screening results by phone. Second zoster dose in two to six months. Call or text 988 at any time in a crisis",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-USPSTF-CRC-2021",
            "GL-USPSTF-STATIN-2022",
            "GL-SUICIDE-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-03-09",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 99.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-12",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 98.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-04-20",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 99.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-06-08",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 100.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-08-24",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 101.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 84,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-07-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 100.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 82,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 84,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 37.4,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 97,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vital signs at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-05",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 190,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 102.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 28.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 130,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Concert singer and stage and film actor, trained in law, whose work has largely stopped: halls cancel his concerts, record companies will not record him, and he cannot travel abroad to perform because his passport is withheld; his income has fallen to a small fraction of what it was",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0004",
            "CLM-0005",
            "CLM-0006"
          ],
          "synthetic_reason": "Synthetic modern work history anchored to his documented career, blacklisting and passport cancellation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Speaks and writes for civil rights and against colonialism; was questioned by a congressional committee last year about his politics and travel",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern history anchored to his documented activism and the 1956 hearing.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Married; lives in an apartment in New York City; no firearm in the home",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic home situation; no relative is given a statement, decision or health fact.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Never smoked; an occasional glass of wine (AUDIT-C 1); no drug use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Used to walk and swim most days; now rarely leaves the apartment",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity history.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Believes his telephone is listened to and that federal agents follow him; given the documented surveillance of people in his position, this is recorded as a realistic concern",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic modern history anchored to the documented federal files on him.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Supports he names: his music and the spirituals he grew up with, his work for civil rights, and old friends from the stage and the movement",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0003"
          ],
          "synthetic_reason": "Synthetic strengths; no relative is given a role.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in daily activities; has stopped practicing and performing, reads little, and has turned down invitations to speak over the past two months",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Tall, courteous and dignified; slowed movements and a quiet voice; mood 'worn through'; constricted affect; thought logical and goal-directed; no delusions or hallucinations; his account of being watched is consistent with the documented surveillance and is not treated as paranoia; insight and judgment good",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "PHQ-9 22 with item 9 scored 1: thoughts on several days that he would be better off dead, without intent or plan; no past suicide attempt; GAD-7 12; MoCA 28",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "safety_assessment": {
      "id": "SAFE-001",
      "date": "2026-03-09",
      "current_ideation": "present",
      "intent": "absent",
      "plan": "absent",
      "access_reviewed": true,
      "protective_factors": [
        "His music and the hope of singing again",
        "His commitment to the civil rights work he has led for decades",
        "Old friends from the stage and the movement",
        "His own decision to come for help",
        "Engagement in care and willingness to make a safety plan"
      ],
      "disposition": "Outpatient care with a psychiatric consultation in three days and close follow-up. C-SSRS screen: wish to be dead on several days in the past month; no active thoughts of suicide, intent, plan, preparation or past attempt. Risk factors reviewed: severe depression, an older man, insomnia, loss of work and income, isolation, and sustained persecution. Means counseling: there is no firearm in the home and he will not acquire one; medicines will be dispensed in limited supplies and kept in a locked box. A written safety plan was made with him, with warning signs, coping steps, people and places for distraction, and crisis numbers; the 988 Suicide & Crisis Lifeline (call or text 988) was saved in his phone. Safety is reviewed at every visit",
      "provenance": {
        "evidence_grade": "S",
        "claim_ids": [
          "CLM-0008"
        ],
        "synthetic_reason": "Synthetic present-day structured safety assessment required by the depression code and PHQ-9; it records passive ideation without intent or plan and makes no claim about his real mental state on any date.",
        "author": "The Human Record generator",
        "created": "2026-11-05T14:00:00-05:00"
      }
    },
    "consultation": {
      "referral": {
        "question": "Probable severe major depression in a 58-year-old singer and actor under sustained political persecution, with passive thoughts of death. Please confirm the diagnosis with a structured interview, screen for bipolar disorder, judge suicide risk and the level of care, and advise on treatment, including when ECT or other treatments would be indicated",
        "urgency": "Urgent, within three days. He has passive thoughts of being better off dead on several days, without intent, plan, preparation or past attempt. A safety plan is in place, there is no firearm at home, his medicines are locked, and he has the 988 Suicide & Crisis Lifeline in his phone. He has been told to call or text 988 or go to the nearest emergency department if the thoughts become active",
        "pertinent_history": "About three months of low mood, exhaustion, waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends. He had a first depression about two years ago after prostate surgery. His concerts and recordings have been cancelled, his passport is withheld, and his income has fallen sharply; he was questioned by a congressional committee last year. He believes he is watched by federal agents, which is consistent with the documented surveillance of people in his position. Never smoked; an occasional glass of wine (AUDIT-C 1); no drugs; no medicines; no known allergy. PHQ-9 22 with item 9 scored 1; GAD-7 12; MoCA 28. C-SSRS screen: wish to be dead on several days; no active ideation. Today: blood pressure 128/80, pulse 76, weight 99.0 kg (BMI 27.4); examination unremarkable apart from slowed speech and constricted affect. Blood count, metabolic panel, calcium, TSH, vitamin B12, folate, morning testosterone and hemoglobin A1c sent; HIV and syphilis tests sent",
        "questions": [
          "Does he meet criteria for recurrent major depression, and is there any sign of bipolar disorder or psychotic features?",
          "How should his concern about surveillance be understood in the assessment?",
          "Can he be treated safely as an outpatient, and what should the safety plan include?",
          "Which psychotherapy and which first antidepressant do you advise, and how should response be measured?",
          "What is the plan if the first or second antidepressant trial fails?",
          "When would ECT be indicated, and what would modern ECT and its alternatives involve for him?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Robeson, a 58-year-old singer, actor and civil rights activist trained in law, is seen at the request of Dr. Bankole-Ashworth three days after his first visit. He describes about three months of low mood, exhaustion, early waking, poor appetite and loss of interest, with withdrawal from friends and from singing. He had a first depression about two years ago, after prostate surgery, that lifted slowly over some months without treatment. Before it he had some weeks of intense, absorbed work, sleeping his usual hours, without elation, irritability, racing thoughts, spending or other risky behavior. He has thoughts on some days that he would be better off dead, without intent or plan, and has never attempted suicide. He has lost most of his work and income, cannot travel abroad, and believes his telephone is listened to. He asked who would see this note and was told",
        "data_reviewed": "Dr. Bankole-Ashworth's intake note, safety assessment and results: PHQ-9 22 (item 9 scored 1), GAD-7 12, MoCA 28; blood count, sodium 140, potassium 4.2, creatinine 1.05 mg/dL, glucose 92, calcium 9.4, TSH 1.8, vitamin B12 420, folate 9.5, morning testosterone 420 ng/dL and A1c 5.6%, all normal; HIV and syphilis tests negative. Structured diagnostic interview today (mood, psychosis, anxiety, trauma and substance modules) and the Mood Disorder Questionnaire (5 of 13 items, not in one period)",
        "exam": [
          {
            "system": "General",
            "finding": "Tall, well groomed and courteous; blood pressure 126/78, pulse 74"
          },
          {
            "system": "Psychiatric",
            "finding": "Psychomotor slowing; quiet speech; mood 'worn through'; constricted affect; logical, goal-directed thought; no delusions or hallucinations; passive thoughts of death without intent or plan; insight and judgment good"
          },
          {
            "system": "Neurological",
            "finding": "No tremor or focal signs"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Major depressive disorder, recurrent, severe, without psychotic features",
            "assessment": "He meets criteria for a second major depressive episode, severe, without psychotic features. The MDQ is negative and the interview finds no past hypomanic or manic episode: the earlier period of intense work did not include reduced need for sleep, elation or irritability, so bipolar disorder is not diagnosed, but he should be watched for activation once an antidepressant starts. The tests exclude the common medical causes. Severe depression with a sustained stressor and passive thoughts of death in an older man needs close follow-up, but he has no intent or plan, good supports and a safety plan, so outpatient care is appropriate"
          },
          {
            "problem_id": "PRB-003",
            "display": "Persecution and surveillance",
            "assessment": "His concern about being watched is plausible, specific and consistent with his circumstances; it is not a delusion, and labelling it as paranoia would be a diagnostic error of the kind documented more often in Black patients. Depression, rather than psychosis, explains his presentation, and the persecution is a real stressor that therapy should address directly"
          }
        ],
        "recommendations": [
          "Outpatient care with the written safety plan, locked medicines, no firearm, the 988 Suicide & Crisis Lifeline, and a C-SSRS screen at every visit; admission if thoughts become active, with intent or a plan",
          "Behavioral activation weekly for about sixteen sessions with a psychologist he chooses, then CBT if needed",
          "Sertraline 50 mg each morning, 100 mg at two weeks, then up to 200 mg by eight weeks as tolerated; sodium at about six weeks; PHQ-9 at every visit, with response as a 50 percent fall and remission as a score below 5",
          "If the PHQ-9 falls by less than a quarter after an adequate trial (at least four to eight weeks at an adequate dose), switch to an SNRI such as venlafaxine extended-release up to 225 mg, with blood pressure checks and 30-day supplies",
          "If a second adequate trial brings only a partial response, treat it as treatment-resistant depression: augmentation with aripiprazole (with metabolic and movement monitoring) or lithium, or ECT, rTMS or esketamine",
          "ECT is not indicated now; it is indicated first for psychotic depression, refusal of food or drink, or acute suicidal risk, and is a choice for treatment-resistant depression. If chosen, it should be given with his own informed consent, under general anesthesia with a muscle relaxant, usually right unilateral with an ultrabrief pulse, two or three times a week in a defined course, with the MoCA repeated before and during the course, and with his right to stop at any time",
          "Repeat the MDQ and review the diagnosis if he develops elation, reduced need for sleep or racing thoughts",
          "Explain how his record is protected and keep the psychiatric notes to what care requires"
        ],
        "communication": "Discussed with Dr. Bankole-Ashworth the same morning; he will prescribe and coordinate the psychologist and social worker, and I am available by phone for each medicine change. Mr. Robeson agreed to the plan and asked that no treatment, especially ECT, be given without his own agreement; he was assured that it would not be",
        "follow_up": "Telephone review with Dr. Bankole-Ashworth at each medicine change, and a further consultation if two antidepressant trials fail or if risk rises"
      },
      "guideline_ids": [
        "GL-APA-DEP-2019",
        "GL-VADOD-MDD-2022",
        "GL-SUICIDE-2024",
        "GL-CMID-2026",
        "GL-APA-ECT-2001",
        "GL-APA-ECT-2024",
        "GL-DISPARITY-2014",
        "GL-WILLIAMS-2007"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He is exhausted, sleeps poorly and has lost the wish to sing, and wants to know what is wrong",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He worries that a psychiatric record could be used against him by the people who have taken his passport and his work",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic patient-centered concern anchored to his documented persecution and the federal files on him.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "He wants to keep working for civil rights and to sing again",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Response to treatment: PHQ-9 down by at least half from 22",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "PHQ-9 6 at about seven months, a 73 percent fall",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic measurement-based-care goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "Remission: PHQ-9 below 5",
        "status": "active",
        "target_date": "2026-10-05",
        "outcome": "Not yet met: PHQ-9 6 six weeks after augmentation; continuing",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic remission goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Stay safe: safety plan in place and reviewed at every visit, with no self-harm",
        "status": "active",
        "target_date": "2026-10-05",
        "outcome": "Met so far: no thoughts of suicide since the first months; safety plan reviewed at every visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Sing again: daily vocal practice and one public engagement a month",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "Daily practice resumed; sang at two community gatherings in the past month",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic functional goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "GOAL-005",
        "display": "Sleep six to seven hours a night",
        "status": "completed",
        "target_date": "2026-10-05",
        "outcome": "About six and a half hours a night",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic sleep goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Evaluation: PHQ-9, GAD-7, AUDIT-C and a cognitive screen (MoCA); blood count, metabolic panel, calcium, TSH, vitamin B12, folate, morning testosterone and hemoglobin A1c, with HIV and syphilis tests, to exclude medical causes; a review of medicines; and a sleep apnea screen",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-DEP-2019",
          "GL-VADOD-MDD-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Urgent psychiatric consultation in three days to confirm the diagnosis with a structured interview, screen for bipolar disorder, judge suicide risk and the level of care, and advise on psychotherapy, medicines, and when ECT or other treatments would be indicated",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-DEP-2019",
          "GL-VADOD-MDD-2022",
          "GL-APA-ECT-2001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Safety: structured suicide-risk assessment, a written safety plan, no firearm in the home, medicines dispensed in limited supplies and kept locked, the 988 Suicide & Crisis Lifeline, and a safety review at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-SUICIDE-2024",
          "GL-VADOD-MDD-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic safety plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Trust and equity: explain who can see his record and how it is protected; a therapist of his choosing, including a Black clinician if he wishes; treat discrimination and persecution as real stressors and record his account of surveillance as realistic; a social worker for help with income and costs; guard against the documented under-treatment of depression in Black patients by measuring response at every visit",
        "status": "completed",
        "guideline_ids": [
          "GL-WILLIAMS-2007",
          "GL-DISPARITY-2014",
          "GL-SPRENGER-2025",
          "GL-APA-DEP-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005",
            "CLM-0006",
            "CLM-0007",
            "CLM-0015"
          ],
          "synthetic_reason": "Synthetic equity plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Treatment: behavioral activation weekly with a psychologist for about sixteen sessions, then CBT if needed; sertraline 50 mg, raised to 100 mg at two weeks and to 200 mg by eight weeks as tolerated; PHQ-9 at every visit with response defined as a 50 percent fall and remission as a score below 5; sodium at about six weeks; switch to an SNRI if the PHQ-9 falls by less than a quarter after an adequate trial, and consider augmentation, ECT, rTMS or esketamine if a second adequate trial brings only a partial response; watch for hypomania after starting an antidepressant",
        "status": "completed",
        "guideline_ids": [
          "GL-APA-DEP-2019",
          "GL-VADOD-MDD-2022",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic treatment plan decided at the psychiatric consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-03-12"
      },
      {
        "id": "INT-006",
        "display": "Switch to venlafaxine extended-release by cross-taper: venlafaxine 75 mg for a week while sertraline is halved, then 150 mg for three weeks and 225 mg; blood pressure at every visit; 30-day supplies because venlafaxine is more dangerous in overdose",
        "status": "completed",
        "guideline_ids": [
          "GL-VADOD-MDD-2022",
          "GL-APA-DEP-2019"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic switch decided at the three-month review.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-06-08"
      },
      {
        "id": "INT-007",
        "display": "Treatment-resistant depression: aripiprazole 2 mg, raised to 5 mg at two weeks, with weight at four, eight and twelve weeks, A1c and lipids at baseline and twelve weeks, and an abnormal involuntary movement examination at baseline and six months; an informed consent discussion about ECT (general anesthesia with a muscle relaxant, right unilateral ultrabrief pulse, two or three treatments a week in a defined course, cognitive testing before and during the course, and the right to stop at any time), with rTMS and esketamine as alternatives; ECT not started now and offered if augmentation fails or if he becomes unable to eat or drink, psychotic or acutely suicidal",
        "status": "completed",
        "guideline_ids": [
          "GL-VADOD-MDD-2022",
          "GL-APA-DEP-2019",
          "GL-APA-ECT-2001",
          "GL-APA-ECT-2024",
          "GL-SPRENGER-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0011"
          ],
          "synthetic_reason": "Synthetic augmentation and ECT decision made at the twenty-four-week review.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-08-24"
      },
      {
        "id": "INT-008",
        "display": "Acute bronchitis: no antibiotic and no chest X-ray with normal vital signs and a normal chest examination; honey, warm drinks and steam; plain guaifenesin if needed; no dextromethorphan, which with venlafaxine can cause serotonin syndrome, and no pseudoephedrine or phenylephrine, which raise blood pressure further on venlafaxine; check labels of combination cold remedies; return for fever, breathlessness, chest pain or a cough lasting more than three weeks",
        "status": "completed",
        "guideline_ids": [
          "GL-ARTI-2016",
          "GL-VADOD-MDD-2022"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan decided at the sick visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-07-27"
      },
      {
        "id": "INT-009",
        "display": "Prevention: stool FIT kit for colorectal screening; the earlier prostate surgery records obtained before any decision on PSA testing; a ten-year cardiovascular risk of about 9 percent discussed, with his choice of diet and activity first and a statin to be reconsidered in a year; hepatitis B and C screening; influenza, PCV20 and the first recombinant zoster dose today, the second zoster dose in two to six months",
        "status": "completed",
        "guideline_ids": [
          "GL-USPSTF-CRC-2021",
          "GL-USPSTF-PROS-2018",
          "GL-USPSTF-STATIN-2022",
          "GL-CDC-IMZ-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic prevention plan decided at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T14:00:00-05:00"
        },
        "recorded_date": "2026-10-05"
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-APA-DEP-2019",
        "title": "APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts",
        "publisher": "American Psychological Association",
        "url": "https://www.apa.org/depression-guideline",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-VADOD-MDD-2022",
        "title": "VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder",
        "publisher": "U.S. Department of Veterans Affairs and Department of Defense",
        "url": "https://www.healthquality.va.gov/guidelines/MH/mdd/",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-APA-ECT-2001",
        "title": "The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association, 2nd edition (record of the American Journal of Psychiatry review, 2002)",
        "publisher": "American Psychiatric Association",
        "url": "https://doi.org/10.1176/appi.ajp.159.2.331",
        "version_or_year": "2001"
      },
      {
        "guideline_id": "GL-APA-ECT-2024",
        "title": "The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. A Task Force Report of the American Psychiatric Association, 3rd edition (Library of Congress catalog record, LCCN 2024014438)",
        "publisher": "American Psychiatric Association Publishing",
        "url": "https://lccn.loc.gov/2024014438",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-SUICIDE-2024",
        "title": "VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide",
        "publisher": "U.S. Department of Veterans Affairs and Department of Defense",
        "url": "https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-WILLIAMS-2007",
        "title": "Williams DR, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry 2007;64(3):305-315",
        "publisher": "Archives of General Psychiatry (PubMed 17339519)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/17339519/",
        "version_or_year": "2007"
      },
      {
        "guideline_id": "GL-SPRENGER-2025",
        "title": "Sprenger S, et al. Retrospective Cohort Study of Racial-Ethnic Disparities in Receipt of Electroconvulsive Therapy, 2016-2021. Psychiatr Serv 2025;76(8):736-740",
        "publisher": "Psychiatric Services (PubMed 40364636)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40364636/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-DISPARITY-2014",
        "title": "Racial disparities in psychotic disorder diagnosis: A review of empirical literature",
        "publisher": "World Journal of Psychiatry (PubMed 25540728)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/25540728/",
        "version_or_year": "2014"
      },
      {
        "guideline_id": "GL-ARTI-2016",
        "title": "Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention",
        "publisher": "American College of Physicians and Centers for Disease Control and Prevention (Annals of Internal Medicine)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/26785402/",
        "version_or_year": "2016"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROS-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-DM-2021",
        "title": "Prediabetes and Type 2 Diabetes: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-for-prediabetes-and-type-2-diabetes",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the bipolar screening decision against the documented 1955 period of intense energy, the antidepressant sequence and trial lengths, aripiprazole augmentation, the decision to defer ECT, and the safety plan."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Rutgers, the Paul Robeson House and Museum, the Dictionary of Welsh Biography, Smithsonian Magazine and the American Yawp reader logged for the biography. The psychiatric history rests on secondary accounts of the Duberman biography (Psychology Today, Kirkus) and a blog quoting his son's book, graded D probable; the bipolar interpretation and his son's allegation are R. The New York Times obituary, the National Archives passport file, the Library of Congress and NMAAHC pages, and Duberman's book itself were not read."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "All psychiatric and suicide claims are marked sensitive. The 1961 suicide attempt is stated once without method detail and placed after the index date; the modern safety assessment records passive ideation without intent or plan, a safety plan, means counseling and the 988 Suicide & Crisis Lifeline. The allegation about intelligence agencies is R and not adopted. His death is recorded in one sentence."
    }
  }
}
